Diabetes affects nearly one in four men in their fifties in South Korea, according to preliminary findings from the 2025 National Health and Nutrition Examination Survey released in September by the Korea Disease Control and Prevention Agency.
The data shows that the prevalence of diabetes among men in that age group reached 24.3%, representing a 7.7 percentage point increase from the 16.6% recorded the previous year, according to Joongang. For all adult men, the prevalence stood at 13.1%.
These figures carry direct financial consequences for consumers because chronic illnesses such as diabetes and hypertension can limit access to standard insurance policies or raise premium costs due to perceived risks of complications. In response to a growing pool of potential customers, insurance companies are moving away from broad acceptance thresholds and toward segmented pricing models that adjust premiums based on specific health states.
Insurance providers are introducing underwriting methods that apply different screening criteria within a single contract. Kyobo Life Insurance introduced a product in June that combines standard and simplified underwriting procedures across separate policy riders. Traditional simplified insurance applies relaxed review standards to all riders, which generally results in higher overall premiums.
The new approach allows policyholders to apply standard screening to eligible riders to secure lower costs.
For example, a 40-year-old man taking hypertension medication who wants coverage for cancer, cerebrovascular disease, and heart conditions can be evaluated through different tracks. Kyobo Life said that its design structure reduced the cancer diagnosis rider premium by approximately 16.2% compared with traditional simplified policies.
The evaluation process also incorporates automated system checks during the design phase to verify whether an applicant qualifies for standard underwriting before they select simplified options. The Life Insurance Association granted this composite underwriting rider an exclusive usage right for six months.
Other financial institutions are diversifying their underwriting categories to differentiate pricing based on specific chronic conditions. Samsung Life Insurance structures its health product with three distinct notice types covering general, standard, and simplified disclosures. Hanwha Life Insurance separates its criteria according to prior hospitalization and surgical history.
Founded as the Central Health Centre in 1949, the Korea Disease Control and Prevention Agency became the Korea Centers for Disease Control and Prevention in 2003 after the SARS outbreak. It was restructured into an expanded agency with vice-ministerial status on September 12, 2020, following the COVID-19 pandemic, gaining a 42% staff increase and greater autonomy. The agency oversees the National Health and Nutrition Examination Survey and operates the National Research Institute of Health.
| Company | Product Name | Underwriting Approach |
|---|---|---|
| Kyobo Life | Kyobo K-Custom Health Insurance | Combines standard and simplified screening by rider |
| Samsung Life | Samsung New Plus One Health Insurance | Divides categories into health, standard, and simplified notice types |
| Hanwha Life | Signature H Integrated Insurance | Splits entry criteria based on hospitalization and surgery history |
| Heungkuk Fire | HeungGood GoDangJi 3.10.5 Simplified Comprehensive Insurance | Divides coverage into seven types based on hypertension, diabetes, and dyslipidemia |
Heungkuk Fire divides its product into seven distinct enrollment types depending on whether a policyholder manages high blood pressure, diabetes, or dyslipidemia.
“Policyholders used to focus simply on whether they could secure coverage, but now it is an era where they can select coverage and premiums tailored to their personal health conditions,” an insurance industry official told JoongAng.
The official added that consumers should comprehensively evaluate not only their approval status but also the rider-specific screening standards and the long-term cost of premium payments.